See Your Insured Work and Your Self-Pay Work as Two Different Businesses

Referrer work, insurer work and the patient who buys directly

A UK private laboratory typically earns from episodes referred by clinicians, episodes funded through private medical insurance, and a growing number of patients who decide for themselves that they want a panel and pay for it. These behave nothing alike. They have different lead times, different points of failure and different people making the decision. Reported as one monthly total, they hide each other.

Funding route as a field, not a footnote

Recording how each episode is funded is a small change with a disproportionate effect. It separates conversion rates that were previously averaged together, shows which stream is actually growing, and makes it obvious when the self-pay side has quietly become significant enough to deserve its own process rather than being absorbed by reception.

The enquiry that never became a booking

Someone who emails to ask what a thyroid or vitamin panel costs has done most of the work of becoming a customer. If the reply goes out and nothing happens afterwards, that enquiry is simply gone, and because it never became a record it never appears in any report. Labs with a healthy direct-to-consumer stream and no pipeline for it are usually converting far less of it than they assume.

Quote, follow up, and measure the close

Treating these enquiries as a pipeline with a quote, an owner and a follow-up step turns an invisible activity into a measurable one. You learn which panels attract enquiries, what proportion convert, and how much of the loss is simply nobody following up on day three. That last figure is usually the uncomfortable one, and it is also the cheapest to fix.

A trend, not a total

The number worth watching for a referring surgery or consultant clinic is the direction of travel. A practice that has halved its volume over two quarters has not raised a complaint and has not gone anywhere; it has started sending some work elsewhere, usually because something was easier there. Without the requesting practice on each episode, that is invisible until it is finished.

Coverage that can be inspected

Most laboratories have someone responsible for maintaining these relationships across a region, and very few can produce a list of which practices were visited in the last two months. Logging the visit against the practice makes the territory reviewable: which high-volume referrers are being looked after, which have been skipped because they are inconvenient, and what happens when the person covering the region changes.

The network average hides the outlier

Phlebotomy clinic performance reported as a network figure tells you very little. One location with a lengthening wait, a transport run leaving fifteen minutes too early, or an unfilled shift will sit comfortably inside a healthy-looking total for months. The signal lives in the comparison between sites.

Domiciliary work is a routing problem

Home and care-home collections arrive as individual requests and are usually handled as individual callbacks, which is how a phlebotomist ends up crossing a county twice in an afternoon. Grouping them into sequenced runs with an arrival window sent to the patient converts the same volume into a planned route, and the time recovered is significant in rural coverage.

The lawful basis is the part people skip

Reminding a patient that a repeat test is due is genuinely useful and genuinely predictable revenue. It also involves processing health data for a purpose the patient needs to have agreed to, and the distinction between a clinical reminder and marketing is one your organisation should settle deliberately. Recording the basis and the contact preference against the patient means a later question is answered with a query rather than a reconstruction, and every message sent stays logged against the record.

Special category data, unchanged duties

Your registration, your accreditation and your handling of patient information remain your responsibility whichever systems you run. A CRM contributes evidence rather than compliance: contact history with timestamps, visible record changes and access limited by role, with the clinical result left in the LIMS. Decide what actually needs to live in the commercial system with your information governance lead, and keep it to the minimum that lets the work happen.